CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-04 | Mehra Anand Director | Grant or award · Restricted Stock Units | +10,987 | 10,987 | ||
| 2026-06-04 | GOWEN MAXINE Director | Grant or award · Stock Option (Right to Buy) | +42,350 | 42,350 | ||
| 2026-06-04 | GOWEN MAXINE Director | Grant or award · Restricted Stock Units | +10,987 | 10,987 | ||
| 2026-06-04 | MILANO VINCENT Director | Grant or award · Stock Option (Right to Buy) | +42,350 | 42,350 | ||
| 2026-06-04 | MILANO VINCENT Director | Grant or award · Restricted Stock Units | +10,987 | 10,987 | ||
| 2026-06-04 | SCHIFF ANDREW N Director | Grant or award · Stock Option (Right to Buy) | +42,350 | 42,350 | ||
| 2026-06-04 | SCHIFF ANDREW N Director | Grant or award · Restricted Stock Units | +10,987 | 10,987 | ||
| 2026-05-01 | Hall Jesse Wayne Chief Medical Officer | Option exercise | +36,375 | 36,375 | ||
| 2026-05-01 | Hall Jesse Wayne Chief Medical Officer | Shares withheld for taxes | −9,330 | $4.41 | $41K | 27,045 |
| 2026-05-01 | Hall Jesse Wayne Chief Medical Officer | Option exercise · Restricted Stock Units | −36,375 | 109,125 | ||
| 2026-04-23 | Leonard Braden Michael 10% owner | Sale | −300,000 | $4.53 | $1.4M | 13,950,000 |
| 2026-03-01 | Balthaser Kevin Chief Financial Officer | Option exercise | +2,375 | 188,130 | ||
| 2026-03-01 | Balthaser Kevin Chief Financial Officer | Shares withheld for taxes | −677 | $2.87 | $2K | 187,453 |
| 2026-03-01 | Balthaser Kevin Chief Financial Officer | Option exercise · Restricted Stock Units | −2,375 | 0 | ||
| 2026-02-03 | Davis Hugh M. President and COO | Option exercise | +18,675 | 45,425 | ||
| 2026-02-03 | Davis Hugh M. President and COO | Option exercise · Restricted Stock Units | −18,675 | 56,025 | ||
| 2026-02-03 | Balthaser Kevin Chief Financial Officer | Option exercise | +22,025 | 192,204 | ||
| 2026-02-03 | Balthaser Kevin Chief Financial Officer | Shares withheld for taxes | −6,449 | $3.47 | $22K | 185,755 |
| 2026-02-03 | Balthaser Kevin Chief Financial Officer | Option exercise · Restricted Stock Units | −22,025 | 66,075 | ||
| 2026-02-03 | Loerop James Chief Business Officer | Option exercise | +20,875 | 198,197 |
Page 2 of 34 · 680 trades